Restart of androgen deprivation therapy after goserelin induced pituitary apoplexy in a patient with disseminated prostate cancer a case report and five-years follow-up.

Aljabri, Belal; Lilleby, Wolfgang; Switlyk, Marta D; Tafjord, Gunnar

Aljabri, Belal; Lilleby, Wolfgang; Switlyk, Marta D; Tafjord, Gunnar.

Afiliación

Aljabri B; Department of Oncology, The Norwegian Radiumhospitalet, Oslo University Hospital, Oslo, Norway.
Lilleby W; Department of Palliative medicine, Akershus University Hospital, Lørenskog, Norway.
Switlyk MD; Department of Oncology, The Norwegian Radiumhospitalet, Oslo University Hospital, Oslo, Norway.
Tafjord G; Department of Radiology, The Norwegian Radiumhospitalet, Oslo University Hospital, Oslo, Norway.

Urol Case Rep ; 37: 101648, 2021 Jul.

Article en En | MEDLINE | ID: mdl-33868933

Palabras clave

Gonadotropin releasing hormone; Goserelin; Pituitary apoplexy; Prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Urol Case Rep Año: 2021 Tipo del documento: Article País de afiliación: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google